| Privacy Policy * |
The information reported by you will be processed exclusively for the purpose of submitting adverse event reports to regulatory agencies and contractual partners.
Non-healthcare professionals are strongly advised to seek medical counsel from a qualified doctor, pharmacist, or healthcare provider prior to making any clinical decisions.
This reporting procedure does not constitute or guarantee any form of financial compensation. For legal consultations or the submission of claims related to pharmaceutical injury relief, please utilize the appropriate channels designated below:
Adverse Event Inquiries : 070-8802-4129 (09:00 ~ 17:00, weekday)
Pharmaceutical ADR(Adverse drug reaction) Relief Program Support : 1644-6223
1. Consent to the Collection and Use of Personal Information
| Purpose of Collection and Use |
Receipt and processing of adverse event reports in accordance with relevant pharmacovigilance laws and regulations. |
| Items to be Collected and Used |
Reporter Information : Name, mobile phone number, email address, qualification (e.g., healthcare professional, patient, etc.)
Patient & Case Information : Patient's gender, age, product name, administration date, dosage, symptoms or diagnosis to be reported, and the start and end dates of the symptoms or diagnosis
|
| Retention and Use Period |
For a minimum of 5 years from the date of document generation or from the decommissioning date of the pharmacovigilance system. |
You have the right to refuse the collection and use of your personal information as stated above. However, please be advised that if you do not agree, we will be unable to accept and process your inquiry.
2. Consent to the Provision of Personal Information to Third Parties
| Purpose of Provision |
Reporting of adverse events in accordance with relevant pharmacovigilance laws, regulations, and Safety Data Exchange Agreements (SDEA). |
| Items to be Provided |
Patient's gender, age, product name, administration date, dosage, symptoms or diagnosis to be reported, and the start and end dates of the symptoms or diagnosis.
|
| Recipients of Personal Information |
Regulatory authorities (Ministry of Food and Drug Safety, Korea Institute of Drug Safety & Management) and domestic/overseas partners. |
| Retention and Use Period by Recipients |
For a minimum of 5 years from the date of document generation or from the decommissioning date of the pharmacovigilance system. |
You have the right to refuse consent to the provision of your personal information to third parties.
|
Direct Call +82-70-8802-4129